How many institutional investors hold CGON?

3 tracked institutional investors disclosed a position in CGON (CG ONCOLOGY INC) in their most recent 13F filing.

Who is the largest institutional holder of CGON?

Ken Griffin, Citadel Advisors, holds the largest disclosed position in CGON, valued at $32M.

Where does this CGON ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

CGON — CG ONCOLOGY INC

Name: CG ONCOLOGY INC (CGON) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About CG ONCOLOGY INC (CGON)

CG ONCOLOGY INC (CGON) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $32M. Across recent filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CGON

100

/100

Strong Institutional Accumulation

Added / Increased4

Reduced0

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track CGON

/100

Emerging Interest

3investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

CGON Ownership Composition

How CG ONCOLOGY INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Hedge Funds

60% of tracked value

Institutions

tracked investors

Total Reported

$48.3M

combined 13F value

Hedge Funds59.6%
Other40.4%

Hedge Funds(1)

59.6%

Other(2)

40.4%

Tracked investors reporting CGON

Investor	Firm	Shares	Market value	% of portfolio	As of
Ken Griffin	Citadel Advisors	267.8K	$18.1M	0.00%	Mar 31, 2026
Steve Cohen	Point72 Asset Management	425.3K	$28.8M	0.04%	Mar 31, 2026
Izzy Englander	Millennium Management	20K	$1.4M	0.00%	Mar 31, 2026

Ken GriffinMar 31, 2026
Citadel Advisors
Shares
267.8K
Value
$18.1M
% Portfolio
0.00%
Steve CohenMar 31, 2026
Point72 Asset Management
Shares
425.3K
Value
$28.8M
% Portfolio
0.04%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
20K
Value
$1.4M
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Izzy Englander	New	—	$6.7M	Feb 17, 2026
Izzy Englander	New	—	$1.4M	May 15, 2026
Steve Cohen	New	—	$6.3M	Feb 17, 2026
Steve Cohen	New	—	$28.8M	May 15, 2026

Izzy Englander
New
$6.7MFeb 17, 2026
Izzy Englander
New
$1.4MMay 15, 2026
Steve Cohen
New
$6.3MFeb 17, 2026
Steve Cohen
New
$28.8MMay 15, 2026

Frequently asked questions

How many institutional investors hold CGON?: 3 tracked institutional investors disclosed a position in CGON (CG ONCOLOGY INC) in their most recent 13F filing.
Who is the largest institutional holder of CGON?: Ken Griffin, Citadel Advisors, holds the largest disclosed position in CGON, valued at $32M.
Did institutional ownership of CGON increase or decrease?: Across recent 13F filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 fully exited CGON.
Where does this CGON ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.